Molecular spectrum of excision repair cross-complementation group 8 gene defects in Chinese patients with Cockayne syndrome type A

被引:11
|
作者
Wang, Xiaozhu [1 ,2 ]
Huang, Yu [2 ]
Yan, Ming [2 ]
Li, Jiuwei [3 ]
Ding, Changhong [3 ]
Jin, Hong [3 ]
Fang, Fang [3 ]
Yang, Yanling [4 ]
Wu, Baiyan [2 ]
Chen, Dafang [1 ]
机构
[1] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China
[2] Peking Univ, Sch Basic Med Sci, Dept Med Genet, Hlth Sci Ctr, Beijing 100191, Peoples R China
[3] Capital Med Univ, Beijing Childrens Hosp, Dept Neurol, Beijing 100045, Peoples R China
[4] Peking Univ, Dept Paediat, Hosp 1, Beijing 100034, Peoples R China
来源
SCIENTIFIC REPORTS | 2017年 / 7卷
基金
中国国家自然科学基金;
关键词
MUTATIONS; ERCC8; DIAGNOSIS; PROTEIN; CSA;
D O I
10.1038/s41598-017-14034-3
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
There are two genetics complementary groups Cockayne syndrome type A and B (CS-A and CS-B OMIM 216400, 133540), which is a rare autosomal recessive segmental progeroid syndrome. Homozygous or compound heterozygous mutations in the excision repair cross-complementation group 8 gene (ERCC8) result in CS-A, and mutations in ERCC6 result in CS-B. Homozygous ERCC6/ERCC8 mutations also result in UV-sensitive syndrome. In this study, twenty-one Han Chinese patients with CS were investigated to identify mutations in ERCC8/ERCC6, of which thirteen cases with CS-A were identified with the mutations of ERCC8. There are five types mutations of ERCC8 in our study, such as exon 4 rearrangement, c.394_398delTTACA, c.299insA, c.843 + 2T > C, and c.2T > A. An estimated frequency of exon 4 rearrangement accounts for 69.23% and c.394_398delTTACA accounts for 11.53% in our cohort. Haplotype analysis revealed that the exon 4 rearrangement and c.394_398delTTACA mutations originated from a common founder in the Chinese population respectively. With the identification of three novel ERCC8 mutations, this study expanded the molecular spectrum of known ERCC8 defects, and furthermore, suggests that the exon 4 rearrangement and c.394_398delTTACA mutations may be a common underlying cause of CS-A in the Chinese population, which is different from that in other populations.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Emodin regulating excision repair cross-complementation group 1 through fibroblast growth factor receptor 2 signaling
    Chen, Gang
    Qiu, Hong
    Ke, Shan-Dong
    Hu, Shao-Ming
    Yu, Shi-Ying
    Zou, Sheng-Quan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (16) : 2481 - 2491
  • [22] Excision repair cross-complementation group 1 (ERCC1) protein expression and clinical outcome in resectable cholangiocarcinoma
    Wirasorn, Kosin
    Sompornrattanaphan, Mongkhon
    Sangkhamannon, Sakkarn
    Waraasawapati, Sakda
    Sookprasert, Aumkhae
    Khuntikao, Narong
    Pakkhem, Ake
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [23] Impact of excision repair cross-complementation group 1 (ERCCI) protein on survival of patients with osteosarcoma treated with cisplatin-based chemotherapy.
    Igarashi, Kentaro
    Yamamoto, Norio
    Shirai, Toshiharu
    Hayashi, Katsuhiro
    Nishida, Hideji
    Kimura, Hiroaki
    Takeuchi, Akihiko
    Miwa, Shinji
    Inatani, Hiroyuki
    Shimozaki, Shingo
    Kato, Takashi
    Tsuchiya, Hiroyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] Excision repair cross-complementation group 1 expression predicts response and survival in locally advanced cervical carcinoma patients treated with concurrent chemoradiotherapy
    Liang, Zhe Long
    Song, Eun-Kee
    Ko, Young Bok
    Lee, Na-Ri
    Yhim, Ho-Young
    Noh, Heung-Tae
    Yun, Hwan Jung
    Suh, Kwang Sun
    Jo, Deog Yeon
    Kim, Samyong
    Kim, Jun-Sang
    Kim, Jin Man
    Lee, Hyo Jin
    HISTOPATHOLOGY, 2011, 59 (03) : 564 - 567
  • [25] Personalized Medicine In Malignant Mesothelioma: Can Thymidylate Synthase And Excision Repair Cross-Complementation Group 1 Predict Response To Chemotherapy?
    Schwed-Lustgarten, D. E.
    Deshpande, C.
    Litzky, L.
    Feldman, M.
    Wang, L. -P.
    Langer, C.
    Inghilleri, S.
    Wang, L.
    Albelda, S. M.
    Stella, G. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [26] The Cockayne Syndrome group B gene product is involved in general genome base excision repair of 8-hydroxyguanine in DNA
    Tuo, J
    Müftüoglu, M
    Chen, C
    Jaruga, P
    Selzer, RR
    Brosh, RM
    Rodriguez, H
    Dizdaroglu, M
    Bohr, VA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (49) : 45772 - 45779
  • [27] Commercial Laboratory Testing of Excision Repair Cross-Complementation Group 1 Expression in Non-Small Cell Lung Cancer
    Schneider, Jeffrey G.
    Farhadfar, Nosha
    Sivapiragasam, Abirami
    Geller, Matthew
    Islam, Shahidul
    Selbs, Elena
    ONCOLOGIST, 2014, 19 (05): : 459 - 465
  • [28] Excision repair cross-complementation group 1 (ERCC1) expression in advanced urothelial carcinoma patients receiving cisplatin-based chemotherapy
    Kim, Kyoung Ha
    Do, In-Gu
    Kim, Hyeong Su
    Chang, Myung Hee
    Kim, Hyo Song
    Jun, Hyun Jung
    Uhm, Jieun
    Yi, Seong Yoon
    Lim, Do Hyoung
    Ji, Sang Hoon
    Park, Min Jae
    Lee, Jeeyun
    Park, Se Hoon
    Kwon, Ghee Young
    Lim, Ho Yeong
    APMIS, 2010, 118 (12) : 941 - 948
  • [29] Clinicopathological significance of excision repair cross-complementation 1 (ERCC1) enzyme status in breast cancer patients
    Schmitt, F.
    Carvalho, A. S.
    Gomes, M.
    Albergaria, A.
    Gerhard, R.
    VIRCHOWS ARCHIV, 2012, 461 : S254 - S254
  • [30] Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer
    Sokbom Kang
    Woong Ju
    Jae Weon Kim
    Noh-Hyun Park
    Yong-Sang Song
    Seung Cheol Kim
    Sang-Yoon Park
    Soon-Beom Kang
    Hyo-Pyo Lee
    Experimental & Molecular Medicine, 2006, 38 : 320 - 324